Enfusion Inc. (ENFN)

ENFN trades at $10.76, 330.4% above the near-term max pain of $2.5 expiring Nov 21, 2025 (94 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($2.5-$97), indicating stable market expectations. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ENFN shows stable levels around 49.75, reflecting balanced market expectations. The 190% spread signals divergent expectations across timeframes. Levels distributed around 10.76. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.